EXCLUSIVE: NICE decision means kids diagnosed with devastating neurodegenerative condition will no longer receive life-lengthening enzyme therapy on NHS ...
We rely on reader and advertising support to fund our reporting. Show your love for Baltimore by powering the stories that illuminate what makes Baltimore unique, and helping to keep access free for ...
The Rich family have seen first hand how much the drug can help children with a devastating Batten disease diagnosis ...
Polaryx Therapeutics (Nasdaq: PLYX), a clinical-stage biotechnology company developing novel, disease-modifying therapies for rare, pediatric lysosomal storage disorders (“LSDs”), joins the global ...
This campaign turns a birthday celebration into a chance to help children around the world. Every bid and every donation helps move research forward.” — Carol Schwimmer, ForeBatten Foundation CHAPEL ...
rhPPT1 is a recombinant protein used to treat an ultra-rare disease called Batten disease CLN1 for which there is currently no FDA approved treatment available. These findings suggest intravenous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results